Your browser doesn't support javascript.
loading
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng, Maximilian Y; Hinz, Felix; Maas, Sybren L N; Anil, Günes; Sievers, Philipp; Conde-Lopez, Cristina; Lischalk, Jonathan; Rauh, Sophie; Eichkorn, Tanja; Regnery, Sebastian; Bauer, Lukas; Held, Thomas; Meixner, Eva; Lang, Kristin; Hörner-Rieber, Juliane; Herfarth, Klaus; Jones, David; Pfister, Stefan M; Jungk, Christine; Unterberg, Andreas; Wick, Wolfgang; von Deimling, Andreas; Debus, Jürgen; Sahm, Felix; König, Laila.
Afiliación
  • Deng MY; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hinz F; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • Maas SLN; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Anil G; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sievers P; Department of Neuropathology, Heidelberg University Hospital and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Conde-Lopez C; Department of Neuropathology, Heidelberg University Hospital and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lischalk J; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Rauh S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Eichkorn T; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • Regnery S; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Bauer L; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Held T; Department of Neuropathology, Heidelberg University Hospital and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Meixner E; Division of Radiooncology-Radiobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lang K; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Health at Long Island, New York, NY, USA.
  • Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Herfarth K; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • Jones D; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Pfister SM; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jungk C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Unterberg A; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • Wick W; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • von Deimling A; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sahm F; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • König L; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Neurooncol Adv ; 5(1): vdad059, 2023.
Article en En | MEDLINE | ID: mdl-37293256
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Alemania